← Back to headlines
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
Biotechnology firm EpiVax has introduced advanced machine learning models designed to improve the accuracy and speed of immunogenicity risk assessments.
2 Sept, 15:19 — 2 Sept, 15:19
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: taiwan-news · 2 Sept, 15:19|Full coverage: 2 · 27m|Window: 27m
Left-leaningCenterRight-leaning
